Drug intelligence / Profile preview

Liu Jiaxiang's Qiyin Syndrome Granules

Development stage: Unknown
Lead developer: Longhua Hospital Shanghai University of Traditional Chinese Medicine
Administration: Oral

Overview

Liu Jiaxiang's Qiyin Syndrome Granules is a Traditional Chinese Medicine (TCM) formulation in granule form. It is being investigated for its efficacy in preventing and treating the recurrence and metastasis of Stage IIIA Non-small Cell Lung Cancer after radical operation. As a TCM, its therapeutic approach is rooted in the principles of syndrome differentiation, aiming for a holistic effect.

Other names: Liu Jiaxiang's Qiyin Syndrome

Beyond the preview

Go deeper on Liu Jiaxiang's Qiyin Syndrome Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Liu Jiaxiang's Qiyin Syndrome Granules.

Explore the full profile